Apeloa Company Limited is principally engaged in the research, development, production and sale of medicines. The Company provides four categories of products: drug substances such as amantadine hydrochloride, drotaverine hydrochloride, lavo-ofloxacin hydrochloride, ofloxacin, ubenimex, alfacalcidol and others; intermediates such as adamantane, 1-adamantanecarboxylic acid, adamantanol, adamantanone and others; chemical preparations such as ubenimex capsules, indapamide tablets, azithromycin sodium dithydrogen citrate for injection, rimantadine hydrochloride oral liquid and others; Chinese traditional medicine preparations such as lentinan tablets, cucurbitacin tablets, tripterygium wilfordii multiglucoside tablets and others.